This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Masako Chuganji: Innovator in Genetic Engineering
Introduction
Masako Chuganji is a prominent inventor based in Hirakata, Japan. She has made significant contributions to the field of genetic engineering, particularly in the development of novel promoters for heterologous protein expression. Her work has implications for various biotechnological applications.
Latest Patents
Masako Chuganji holds a patent for a mutant AOX2 promoter, which is a significant advancement over the natural AOX2 promoter. The patent describes a mutant AOX2 promoter obtained by mutating a sequence of the natural AOX2 promoter. This includes at least one of three mutation modes: deleting a region extending upstream from nucleotide 1187, replacing nucleotides in specific regions, and inserting new oligonucleotides. The resulting promoter exhibits remarkably enhanced activity compared to the natural version, making it highly useful for expression vectors that facilitate heterologous protein expression. The vector and transformant associated with this invention can efficiently express and produce various useful heterologous proteins.
Career Highlights
Masako Chuganji is affiliated with The Green Cross Corporation, where she continues to innovate in the field of biotechnology. Her work has garnered attention for its potential to improve protein production processes.
Collaborations
Masako has collaborated with notable colleagues, including Shusei Uno and Ryuji Hiramatsu, contributing to advancements in their shared field of expertise.
Conclusion
Masako Chuganji's contributions to genetic engineering, particularly through her patented mutant AOX2 promoter, highlight her role as an influential inventor in biotechnology. Her work continues to pave the way for advancements in protein expression technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
